Rat Anti-AGER Recombinant Antibody (V2-82149) (CBMAB-R0382-CN)
Phase images (left panels) and immunostains (right) of epithelial progenitors purified from tips of e16.5 lungs and cultured in Matrigel for the period indicated with media alone (Control, top panels) or media supplemented every two days with Fgf7 (50 ng/ml, middle panels) or Fgf10 (100 ng/ml) and HSPG (100 ng/ml, lower panels). Note an increase in luminal surface area (dashed lines) and basal extrusion (arrowheads) in cultures with Fgf ligands, and differentiation into intermingled cuboidal AT2 (Sftpcpos, green) and squamous AT1 cells (RAGEpos, red) at day 4 ("alveolospheres"). In control cultures lacking FGFs (top row) or treated both with Fgf7 and the Fgfr inhibitor FIIN-1 (bottom panel), cells remained bipotent progenitors throughout, as shown by co-expression of both markers. nAT1, nascent AT1 cell; nAT2, nascent AT2 cell. Bars, 50 µm (left panels and right +Fgf7 panel), 10 µm (right top and +Fgf10 panels), and 10 µm (Fgf7 + FIIN-1 panel). Co-treatment with both Fgf7 and Fgf10 (with HSPG) gave similar results as each treatment alone. Quantification at right gives the percent of each cell type (BP), AT1, AT2) in the culture at day 4 determined by immunostaining (n = 348 cells scored for control, 843 for Fgf7-treatment, and 1365 for Fgf10-treatment in experimental triplicate). ***p = 7.7 × 10−28 for Fgf7-treatment and 6.4 × 10−26 for Fgf10-treatment (Student's two-sided t-test), BP abundance of either Fgf treatment condition vs control. ...View More
(A) and (B) cells were incubated with anti-RAGE Mab followed by Alexa Fluor 488 secondary antibody. (C) and (D) cells were stained with 3B4-Cy5 and M4-Cy5 (n ≥ 3, ± SEM, *** p < 0.005 to the untreated cells). ...View More
Basic Information
| Application | Note |
| WB | 2 μg/ml |
| IHC | 8-25 μg/ml |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Cell surface receptor signaling pathway
Cellular response to amyloid-beta
Glucose mediated signaling pathway
Induction of positive chemotaxis
Inflammatory response
Innate immune response
Learning or memory
Microglial cell activation
Modulation of age-related behavioral decline
Negative regulation of blood circulation
Negative regulation of connective tissue replacement involved in inflammatory response wound healing
Negative regulation of interleukin-10 production
Negative regulation of long-term synaptic depression
Negative regulation of long-term synaptic potentiation
Neuron projection development
Positive regulation of activated T cell proliferation
Positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process
Positive regulation of chemokine production
Positive regulation of dendritic cell differentiation
Positive regulation of endothelin production
Positive regulation of ERK1 and ERK2 cascade
Positive regulation of heterotypic cell-cell adhesion
Positive regulation of interleukin-12 production
Positive regulation of interleukin-1 beta production
Positive regulation of interleukin-6 production
Positive regulation of JNK cascade
Positive regulation of JUN kinase activity
Positive regulation of monocyte chemotactic protein-1 production
Positive regulation of monocyte extravasation
Positive regulation of NF-kappaB transcription factor activity
Positive regulation of NIK/NF-kappaB signaling
Positive regulation of p38MAPK cascade
Positive regulation of protein phosphorylation
Positive regulation of tumor necrosis factor production
Protein localization to membrane
Regulation of CD4-positive, alpha-beta T cell activation
Regulation of DNA binding
Regulation of inflammatory response
Regulation of long-term synaptic potentiation
Regulation of NIK/NF-kappaB signaling
Regulation of p38MAPK cascade
Regulation of spontaneous synaptic transmission
Regulation of synaptic plasticity
Regulation of T cell mediated cytotoxicity
Response to amyloid-beta
Response to hypoxia
Response to wounding
Transcytosis
Transport across blood-brain barrier
Isoform 2: Secreted
Isoform 10: Cell membrane
Helical: 343-363 aa
Cytoplasmic: 364-404 aa
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Rabbit Anti-AGER Recombinant Antibody (V2-82145) (CAT#: CBMAB-R0378-CN)
Mouse Anti-AGER Recombinant Antibody (V2-82163) (CAT#: CBMAB-R0396-CN)
Mouse Anti-AGER Recombinant Antibody (V2-82154) (CAT#: CBMAB-R0387-CN)
Rat Anti-AGER Recombinant Antibody (V2-82047) (CAT#: CBMAB-R0084-CN)
Mouse Anti-AGER Recombinant Antibody (V2-180160) (CAT#: CBMAB-A1580-YC)
Rabbit Anti-AGER Recombinant Antibody (V2-6093) (CAT#: CBMAB-0038CQ)
Mouse Anti-AGER Recombinant Antibody (V2-82164) (CAT#: CBMAB-R0397-CN)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

